 Liminal BioSciences Inc. Nasdaq: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company today announced that Kenneth Galbraith, Chief Executive Officer at Liminal BioSciences is scheduled to present a company overview at Canaccord 40th Annual Growth Conference on Thursday 13th August 2:00-2:25 PM EDT. 